Company: DRTSW
Filing Date: 2025-03-12
Form Type: 20-F
Source: 0001213900-25-023187
Chunk: 92

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-03-12
Form: 20-F
Item: Item 3
Chunk 92
---
 and surplus, general financial condition, contractual restrictions and
other factors that our directors may deem relevant. The Israeli Companies Law, 1999 (the “ Companies Law”) imposes restrictions
on our ability to declare and pay dividends. See the section titled “ Dividend and Liquidation Rights” in Exhibit 2.1
to this Annual Report. Payment of dividends may also be subject to Israeli withholding taxes. See the section titled “ Certain
Material Israeli Tax Considerations” for additional information.

The market price and trading volume of our
ordinary shares may be volatile and could decline significantly.

The stock markets, including
Nasdaq on which we have listed our ordinary shares and our warrants under the symbol “ DRTS,” and “ DRTSW,” respectively,
have from time to time experienced significant price and volume fluctuations. Even if an active, liquid and orderly trading market develops
and is sustained for our ordinary shares and our warrants, the market price of our ordinary shares and our warrants may be volatile and
could decline significantly. In addition, the trading volume in our ordinary shares and our warrants may fluctuate and cause significant
price variations to occur. If the market price of our ordinary shares and our warrants declines significantly, you may be unable to resell
your shares or warrants at or above the market price of the ordinary shares and warrants as of the date immediately following the date
of this Annual Report. We cannot assure you that the market price of our ordinary shares and our warrants will not fluctuate widely or
decline significantly in the future in response to a number of factors, including, among others, the following:

  the realization of any of the                  

  additions and departures of  

  failure to comply with the  

  failure to comply with the                        

  publication of research reports  

  the performance and market              

  new laws, regulations, subsidies,                                     

  commencement of, or involvement  

  broad disruptions in the financial                            

  speculation in the press or  

  actual, potential or perceived              

  changes in accounting principles,  
  policies and guidelines; and       
 ─────────────────────────────────────

  other events or factors, including                                                                                                          

In the past, securities class-action
litigation has often been instituted against companies following periods of volatility in the market price of their shares. This type
of litigation could result in substantial costs and divert our management’s attention and resources, which could have a material
adverse effect on us.

Our quarterly operating results may fluctuate